NewsRoom Articles - Page 142 of 229

TuesdayJan 18, 2022 9:30 am

AI Could Help Relieve Physician Stress

A report recently released by Medscape shows that more than 40% of physicians in the United States suffer from burnout. Burnout not only affects individuals emotionally but also impacts finances negatively, with data from the American Medical Association showing that burnout costs healthcare organizations $500,000 to $1 million per physician. The cost of burnout also includes indirect costs such as decreased patient satisfaction, lost patient care revenue, higher risk of malpractice suits, medical errors and damage to the reputation of the healthcare organization. The pandemic has only made things worse, with stress becoming a severe issue for doctors these last…

FridayJan 14, 2022 9:30 am

Study Finds That PTSD Symptoms Change During Menstrual Cycle

A new study has found that over the course of the menstrual cycle, the symptoms of post-traumatic stress disorder may vary, with fewer symptoms presenting as a woman moves closer to ovulation and more symptoms presenting during the first few days of the cycle. The study was carried out by researchers from the Thomas Jefferson University, with its findings being published in the “Psychological Trauma: Theory, Research, Practice and Policy Journal.” The researchers found that estradiol, which is an estrogen hormone produced in the female body, was responsible for this change. This hormone regulates the reproductive cycle in women. The…

ThursdayJan 13, 2022 9:30 am

Long-Term Opioid Users at Risk of Depression, Study Finds

A new study has found that near-daily or everyday use of prescription opioids is linked to a higher risk of new onset depression, in comparison with occasional use of the drugs. While the number of new opioid prescriptions in the United States has dropped since 2012, the average duration of prescriptions and the proportion of 30-day opioid prescriptions increased between 2006 and 2017. The study was conducted by researchers at St. Louis University School of Medicine, led by Jeffrey Scherrer, the institution’s senior director of the Advanced Health Data Institute. Scherrer stated that the risk for new depression episodes in…

WednesdayJan 12, 2022 9:30 am

Researchers Explore How Pandemic Impacted Breast Cancer Screening in Low-Income Populations

After lung cancer, breast cancer is the deadliest type of cancer in the world, affecting women of all ages. Estimates show that about 13% of women develop the deadly cancer in their lifetime. In 2020, more than 2.2 million women were diagnosed with breast cancer, with some 680,000 succumbing to the ailment. These stats highlight the importance of early detection, which is mainly accomplished through breast cancer screening, in helping reduce mortality. Unfortunately, the onset of the coronavirus pandemic caused many postponements and cancellations in screenings not only for breast cancer but also other types of cancer. As a result,…

WednesdayJan 12, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Notes ‘Milestone’ Step with USPTO Notice of Allowance CYB004

Cybin awarded notice for company’s innovative treatment of anxiety disorders Approval demonstrates company’s dedication to discovery and development of psychedelic-based compounds for addressing mental health Anxiety disorders rank among the most common mental illnesses in the country Cybin (NEO: CYBN) (NYSE American: CYBN) has taken another step forward in its strategic plan to strengthen its position as leading innovator in developing putative psychedelic compounds. The company has received a Notice of Allowance from the U.S. Patent and Trademark Office (“USPTO”) for its patent application for an innovative treatment of anxiety disorders (https://ibn.fm/8hMWh). Cybin announced that it has been awarded a USPTO…

TuesdayJan 11, 2022 9:30 am

Study Finds Telehealth Improved Access to Perinatal Mental Healthcare During Pandemic

A new study has found that the use of telehealth for mental health services for infants and mothers in the course of the pandemic improved access to care. Perinatal anxiety and mood disorders occur after or during pregnancy. These disorders are associated with problems with an infant’s emotional and social development as well as poorer birth outcomes. Mothers with high psychosocial stress and low social support have a higher chance of developing perinatal disorders. The coronavirus pandemic disrupted social interactions and increased social isolation, which raised some concerns for the mental health of pregnant mothers. Limited in-person interactions became the…

MondayJan 10, 2022 1:24 pm

Deep Learning Model Could Accurately Classify Brain Tumors After One MRI Scan

Scientists from the School of Medicine at Washington University have created a deep-learning model that can classify brain tumors using an MRI scan. One of the researchers involved in the study, Satrajit Chakrabarty, stated that the research was the first to identify the absence or presence of a tumor from an MRI scan and directly determine the tumor class. The most common types of intracranial tumors include acoustic neuroma, pituitary adenoma, meningioma, brain metastases, low-grade glioma and high-grade glioma. Each tumor type was documented via histopathology, which involves the surgical removal of tissue from the site of a cancer and…

MondayJan 10, 2022 12:22 pm

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: ONFA) Announces Completion of Target-Based Model in Its AI-Driven Drug Discovery Program

The AI-driven drug discovery program uses not only artificial intelligence but also machine learning, which is a relatively new concept and is continuously expanding The use of artificial intelligence in the drug development space may help eliminate or reduce the manual operations that a company typically must undergo to identify and make necessary improvements to drugs The new model will allow the company to rapidly screen billions of structures promoting near term patent filings for novel psychedelic molecules Mydecine has already been able to eliminate unsuccessful candidates early on with the use of this technology Mydecine’s primary focus is the…

MondayJan 10, 2022 10:27 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO Participation in Upcoming Events Recognizes Company Expertise

CEO to participate in panel discussion, fireside chat focusing on psychedelics The company is engineering next-generation psychedelic molecules as it works to transform the mental health treatment landscape CYBN is implementing a three-pillar strategy Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics, is gaining recognition as a leader in the psychedelic space. Evidence of this can be seen in the Cybin CEO’s upcoming participation in two virtual investor conferences (https://ibn.fm/1zAF4). The company announced that CEO Doug Drysdale has been invited to participate in a panel discussion titled "Psychedelics: More Than Just a Trip" during…

FridayJan 07, 2022 10:48 am

Review Finds Ketamine Effective in Treating Mental Health Disorders

Ketamine is a dissociative anesthetic that is used to induce loss of consciousness for medical procedures that don’t need muscle relaxation. Its effects include decreased sensation of pain and sedation. In addition to this, the drug possesses hallucinogenic properties that produce hallucinations similar to other drugs such as LSD. Research has shown that the use of low doses of ketamine in treating treatment-resistant depression is effective, with ongoing trials finding that the drug could also be used to effectively treat other psychiatric conditions. Recent research by Cambridge University Press explores how ketamine works in treating mental health conditions. For their…